Skip to Main content Skip to Navigation
Journal articles

Cancer-testis Antigen FATE1 Expression in Adrenocortical Tumors Is Associated with A Pervasive Autoimmune Response and Is A Marker of Malignancy in Adult, but Not Children, ACC

Abstract : The SF-1 transcription factor target gene FATE1 encodes a cancer-testis antigen that has an important role in regulating apoptosis and response to chemotherapy in adrenocortical carcinoma (ACC) cells. Autoantibodies directed against FATE1 were previously detected in patients with hepatocellular carcinoma. In this study, we investigated the prevalence of circulating anti-FATE1 antibodies in pediatric and adult patients with adrenocortical tumors using three different methods (immunofluorescence, ELISA and Western blot). Our results show that a pervasive anti-FATE1 immune response is present in those patients. Furthermore, FATE1 expression is a robust prognostic
Document type :
Journal articles
Complete list of metadatas

Cited literature [35 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02508381
Contributor : Enzo Lalli <>
Submitted on : Saturday, March 14, 2020 - 2:32:24 PM
Last modification on : Wednesday, July 8, 2020 - 3:47:03 AM

File

Cancers 2020b.pdf
Publisher files allowed on an open archive

Identifiers

Citation

Mabrouka Doghman-Bouguerra, Pascal Finetti, Nelly Durand, Ivy Zortéa Parise, Silviu Sbiera, et al.. Cancer-testis Antigen FATE1 Expression in Adrenocortical Tumors Is Associated with A Pervasive Autoimmune Response and Is A Marker of Malignancy in Adult, but Not Children, ACC. Cancers, MDPI, 2020, 12, ⟨10.3390/cancers12030689⟩. ⟨inserm-02508381⟩

Share

Metrics

Record views

120

Files downloads

221